FI880409A0 - Transdermalt absorberande doseringsenhet foer estradiol och andra estrogena steroider och administrationsfoerfarande. - Google Patents
Transdermalt absorberande doseringsenhet foer estradiol och andra estrogena steroider och administrationsfoerfarande.Info
- Publication number
- FI880409A0 FI880409A0 FI880409A FI880409A FI880409A0 FI 880409 A0 FI880409 A0 FI 880409A0 FI 880409 A FI880409 A FI 880409A FI 880409 A FI880409 A FI 880409A FI 880409 A0 FI880409 A0 FI 880409A0
- Authority
- FI
- Finland
- Prior art keywords
- estradiol
- och
- transdermalt
- steroider
- estrogena
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/868,709 US4883669A (en) | 1985-02-25 | 1986-05-30 | Transdermal absorption dosage unit for estradiol and other estrogenic steroids and process for administration |
PCT/US1987/001202 WO1987007138A1 (en) | 1986-05-30 | 1987-05-29 | Transdermal absorption dosage unit for estradiol and other estrogenic steroids and process for administration |
Publications (2)
Publication Number | Publication Date |
---|---|
FI880409A FI880409A (fi) | 1988-01-29 |
FI880409A0 true FI880409A0 (fi) | 1988-01-29 |
Family
ID=25352181
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI880409A FI880409A0 (fi) | 1986-05-30 | 1988-01-29 | Transdermalt absorberande doseringsenhet foer estradiol och andra estrogena steroider och administrationsfoerfarande. |
Country Status (11)
Country | Link |
---|---|
US (1) | US4883669A (fi) |
EP (1) | EP0269696B1 (fi) |
JP (1) | JP2579982B2 (fi) |
KR (1) | KR960000553B1 (fi) |
AT (1) | ATE109343T1 (fi) |
AU (2) | AU7489587A (fi) |
CA (1) | CA1300019C (fi) |
DE (1) | DE3750327T2 (fi) |
DK (1) | DK41988D0 (fi) |
FI (1) | FI880409A0 (fi) |
WO (1) | WO1987007138A1 (fi) |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5145682A (en) * | 1986-05-30 | 1992-09-08 | Rutgers, The State University Of New Jersey | Transdermal absorption dosage unit for postmenopausal syndrome treatment and process for administration |
US5560922A (en) * | 1986-05-30 | 1996-10-01 | Rutgers, The State University Of New Jersey | Transdermal absorption dosage unit using a polyacrylate adhesive polymer and process |
CH674618A5 (fi) * | 1987-04-02 | 1990-06-29 | Ciba Geigy Ag | |
US5474783A (en) | 1988-03-04 | 1995-12-12 | Noven Pharmaceuticals, Inc. | Solubility parameter based drug delivery system and method for altering drug saturation concentration |
US5656286A (en) * | 1988-03-04 | 1997-08-12 | Noven Pharmaceuticals, Inc. | Solubility parameter based drug delivery system and method for altering drug saturation concentration |
US5019395A (en) * | 1988-03-08 | 1991-05-28 | Warner-Lambert Company | Compositions with enhanced penetration |
US4865920A (en) * | 1988-09-20 | 1989-09-12 | Dow Corning Corporation | Hot-melt pressure sensitive adhesive article and method of making |
WO1990006120A1 (en) * | 1988-12-01 | 1990-06-14 | Schering Corporation | Compositions for transdermal delivery of estradiol |
US4978532A (en) * | 1989-08-11 | 1990-12-18 | Pharmedic Co. | Dosage form for administration of dehydroepiandrosterone |
US5252334A (en) * | 1989-09-08 | 1993-10-12 | Cygnus Therapeutic Systems | Solid matrix system for transdermal drug delivery |
WO1991018572A1 (en) * | 1990-06-01 | 1991-12-12 | Robertson, Dale, N. | Device for transdermal administration of drugs |
JPH07503700A (ja) * | 1991-01-03 | 1995-04-20 | アルカーメス コントロールド セラピューティックス, インコーポレイテッド | カチオン生体ポリマーによるタンパク質の安定化 |
DE4116912A1 (de) * | 1991-05-18 | 1992-11-26 | Schering Ag | Mittel zur transdermalen applikation enthaltend ergolin-derivate |
US5300299A (en) * | 1991-07-22 | 1994-04-05 | Dow Corning Corporation | Silicone pressure sensitive adhesive containing alkylmethylsiloxane wax and related methods and devices |
DE4336557C2 (de) | 1993-05-06 | 1997-07-17 | Lohmann Therapie Syst Lts | Estradiolhaltiges transdermales therapeutisches System, Verfahren zu seiner Herstellung und seine Verwendung |
US5505948A (en) * | 1993-06-01 | 1996-04-09 | Dermatology Home Products, Inc. | Home skin peel composition for producing healthy and attractive skin |
BR9408457A (pt) * | 1993-12-27 | 1997-08-05 | Akzo Nobel Nv | Preparação farmacêutica percutânia |
DE4400770C1 (de) * | 1994-01-13 | 1995-02-02 | Lohmann Therapie Syst Lts | Wirkstoffhaltiges Pflaster zur Abgabe von Estradiol mit mindestens einem Penetrationsverstärker, Verfahren zu seiner Herstellung und seine Verwendung |
AU5971294A (en) * | 1994-01-27 | 1995-08-15 | Schering Aktiengesellschaft | Agent, intended for transdermal administration, containing 14alpha,17alpha-ethanoestra-1,3,5(10)-triene-3,17beta -diol |
DE69517816T2 (de) | 1994-09-14 | 2000-12-28 | Minnesota Mining & Mfg | Matrix für transdermale wirkstofffreisetzung |
DE19500662C2 (de) * | 1995-01-12 | 2001-04-26 | Lohmann Therapie Syst Lts | Estradiolhaltiges Pflaster und seine Verwendung |
UA48973C2 (uk) * | 1995-06-07 | 2002-09-16 | Орто-Макнейл Фармасьютікалз Інк. | Трансдермальний пластир на основі 17-деацетилноргестимату для попередження овуляції |
US5861431A (en) * | 1995-06-07 | 1999-01-19 | Iotek, Inc. | Incontinence treatment |
US5906830A (en) * | 1995-09-08 | 1999-05-25 | Cygnus, Inc. | Supersaturated transdermal drug delivery systems, and methods for manufacturing the same |
FR2749586B1 (fr) * | 1996-06-11 | 1998-08-07 | Hoechst Marion Roussel Inc | Nouveaux dispositifs destines a l'administration transdermique de la trimegestone, leur procede de preparation et leur application a titre de medicaments |
DE19643959A1 (de) * | 1996-10-31 | 1998-05-07 | Lohmann Therapie Syst Lts | Kleber, enthaltend Polymere mit einem sehr geringen Gehalt an Restmonomeren, ein Verfahren zu ihrer Herstellung und ihre Verwendung |
US6488940B2 (en) | 1997-08-21 | 2002-12-03 | Johnson & Johnson Consumer Companies, Inc. | Use of 17-α-estradiol for the treatment of aged or sundamaged skin and/or skin atrophy |
WO1999008654A1 (en) * | 1997-08-21 | 1999-02-25 | Johnson & Johnson Consumer Companies, Inc. | USE OF 17-α-ESTRADIOL FOR THE TREATMENT OF AGED OR SUNDAMAGED SKIN AND/OR SKIN ATROPHY |
US5968919A (en) * | 1997-10-16 | 1999-10-19 | Macrochem Corporation | Hormone replacement therapy drug formulations for topical application to the skin |
US6692763B1 (en) * | 1998-11-19 | 2004-02-17 | The Regents Of The University Of California | Methods for treating postmenopausal women using ultra-low doses of estrogen |
DE19834007C1 (de) | 1998-07-29 | 2000-02-24 | Lohmann Therapie Syst Lts | Estradiolhaltiges Pflaster zur transdermalen Applikation von Hormonen und seine Verwendung |
AU5325000A (en) * | 1999-06-05 | 2000-12-28 | David Houze | Solubility enhancement of drugs in transdermal drug delivery systems and methodsof use |
DE19958554C2 (de) * | 1999-07-02 | 2002-06-13 | Lohmann Therapie Syst Lts | Mikroreservoirsystem auf Basis von Polysiloxanen und ambiphilen Lösemitteln und ihre Herstellung |
ATE234081T1 (de) | 1999-07-02 | 2003-03-15 | Lohmann Therapie Syst Lts | Mikroreservoirsystem auf basis von polysiloxanen und ambiphilen lösemitteln |
US6221384B1 (en) | 1999-11-05 | 2001-04-24 | Anthony C. Pagedas | Segmented transdermal dosage unit |
US7384650B2 (en) * | 1999-11-24 | 2008-06-10 | Agile Therapeutics, Inc. | Skin permeation enhancement composition for transdermal hormone delivery system |
US20020004065A1 (en) | 2000-01-20 | 2002-01-10 | David Kanios | Compositions and methods to effect the release profile in the transdermal administration of active agents |
DE10157745A1 (de) * | 2001-11-24 | 2003-06-26 | Hf Arzneimittelforsch Gmbh | Transdermales therapeutisches System zur Verabreichung von 17alpha-Estradiol |
US9205062B2 (en) * | 2004-03-09 | 2015-12-08 | Mylan Pharmaceuticals, Inc. | Transdermal systems containing multilayer adhesive matrices to modify drug delivery |
US20050202073A1 (en) * | 2004-03-09 | 2005-09-15 | Mylan Technologies, Inc. | Transdermal systems containing multilayer adhesive matrices to modify drug delivery |
WO2012059803A1 (en) * | 2010-11-04 | 2012-05-10 | Lupin Limited | Improved process for preparation of estradiol valerate and a novel crystalline form a of estradiol divalerate |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3598123A (en) * | 1969-04-01 | 1971-08-10 | Alza Corp | Bandage for administering drugs |
US3996934A (en) * | 1971-08-09 | 1976-12-14 | Alza Corporation | Medical bandage |
US4053580A (en) * | 1975-01-01 | 1977-10-11 | G. D. Searle & Co. | Microsealed pharmaceutical delivery device |
US4291014A (en) * | 1979-01-11 | 1981-09-22 | Key Pharmaceuticals, Inc. | Polymeric diffusion matrix containing estradiol diacetate |
US4438139A (en) * | 1979-08-14 | 1984-03-20 | Key Pharmaceuticals, Inc. | Polymeric diffusion matrix containing estrogens |
US4291015A (en) * | 1979-08-14 | 1981-09-22 | Key Pharmaceuticals, Inc. | Polymeric diffusion matrix containing a vasodilator |
SU1243627A3 (ru) * | 1979-12-05 | 1986-07-07 | Дзе Кендалл Компани (Фирма) | Гелеобразующа композици |
US4286592A (en) * | 1980-02-04 | 1981-09-01 | Alza Corporation | Therapeutic system for administering drugs to the skin |
US4336243A (en) * | 1980-08-11 | 1982-06-22 | G. D. Searle & Co. | Transdermal nitroglycerin pad |
US4460372A (en) * | 1981-02-17 | 1984-07-17 | Alza Corporation | Percutaneous absorption enhancer dispenser for use in coadministering drug and percutaneous absorption enhancer |
US4379454A (en) * | 1981-02-17 | 1983-04-12 | Alza Corporation | Dosage for coadministering drug and percutaneous absorption enhancer |
US4585452A (en) * | 1983-04-12 | 1986-04-29 | Key Pharmaceuticals, Inc. | Transdermal systemic dosage forms |
US4559222A (en) * | 1983-05-04 | 1985-12-17 | Alza Corporation | Matrix composition for transdermal therapeutic system |
DE3333240A1 (de) * | 1983-09-12 | 1985-03-28 | Schering AG, 1000 Berlin und 4709 Bergkamen | Mittel zur transdermalen applikation von arzneimittelwirkstoffen |
US4693887A (en) * | 1983-09-15 | 1987-09-15 | The Kendall Company | Microphase separated hydrogels for controlled release of bioactive materials |
US4573996A (en) * | 1984-01-03 | 1986-03-04 | Jonergin, Inc. | Device for the administration of an active agent to the skin or mucosa |
US4624665A (en) * | 1984-10-01 | 1986-11-25 | Biotek, Inc. | Method of transdermal drug delivery |
US4568343A (en) * | 1984-10-09 | 1986-02-04 | Alza Corporation | Skin permeation enhancer compositions |
ATE95430T1 (de) * | 1984-12-22 | 1993-10-15 | Sanol Arznei Schwarz Gmbh | Wirkstoffpflaster. |
ATE77962T1 (de) * | 1985-02-25 | 1992-07-15 | Univ Rutgers | Dosierungssystem fuer transdermale absorption von arzneimittelwirkstoffen. |
US4690683A (en) * | 1985-07-02 | 1987-09-01 | Rutgers, The State University Of New Jersey | Transdermal varapamil delivery device |
CA1288698C (en) * | 1985-08-30 | 1991-09-10 | Yie W. Chien | Transdermal anti-anginal pharmaceutical dosage |
US4666441A (en) * | 1985-12-17 | 1987-05-19 | Ciba-Geigy Corporation | Multicompartmentalized transdermal patches |
-
1986
- 1986-05-30 US US06/868,709 patent/US4883669A/en not_active Expired - Fee Related
-
1987
- 1987-05-29 AT AT87903790T patent/ATE109343T1/de not_active IP Right Cessation
- 1987-05-29 KR KR1019880700098A patent/KR960000553B1/ko not_active IP Right Cessation
- 1987-05-29 AU AU74895/87A patent/AU7489587A/en not_active Abandoned
- 1987-05-29 CA CA000538396A patent/CA1300019C/en not_active Expired - Lifetime
- 1987-05-29 EP EP87903790A patent/EP0269696B1/en not_active Expired - Lifetime
- 1987-05-29 DE DE3750327T patent/DE3750327T2/de not_active Expired - Fee Related
- 1987-05-29 JP JP62503419A patent/JP2579982B2/ja not_active Expired - Lifetime
- 1987-05-29 WO PCT/US1987/001202 patent/WO1987007138A1/en active IP Right Grant
-
1988
- 1988-01-28 DK DK041988A patent/DK41988D0/da unknown
- 1988-01-29 FI FI880409A patent/FI880409A0/fi not_active Application Discontinuation
-
1991
- 1991-04-22 AU AU75268/91A patent/AU635182B2/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
US4883669A (en) | 1989-11-28 |
JP2579982B2 (ja) | 1997-02-12 |
EP0269696A1 (en) | 1988-06-08 |
FI880409A (fi) | 1988-01-29 |
EP0269696B1 (en) | 1994-08-03 |
ATE109343T1 (de) | 1994-08-15 |
DE3750327T2 (de) | 1994-12-08 |
AU7489587A (en) | 1987-12-22 |
DK41988A (da) | 1988-01-28 |
JPH01501146A (ja) | 1989-04-20 |
AU635182B2 (en) | 1993-03-11 |
KR960000553B1 (ko) | 1996-01-09 |
WO1987007138A1 (en) | 1987-12-03 |
AU7526891A (en) | 1991-09-12 |
DE3750327D1 (de) | 1994-09-08 |
EP0269696A4 (en) | 1990-02-06 |
CA1300019C (en) | 1992-05-05 |
DK41988D0 (da) | 1988-01-28 |
KR880701114A (ko) | 1988-07-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI880409A (fi) | Transdermalt absorberande doseringsenhet foer estradiol och andra estrogena steroider och administrationsfoerfarande. | |
ES2074982T3 (es) | Unidad de dosificacion transdermica de estrogeno/progestina, y estuche de control de la fertilidad que comprende dicha unidad de dosificacion. | |
ES2087149T3 (es) | Unidad y sistema de dosificacion transdermica de estrogeno/progestina. | |
ATE77962T1 (de) | Dosierungssystem fuer transdermale absorption von arzneimittelwirkstoffen. | |
PT81751B (pt) | Processo para a preparacao de adesivos para aplicacao de medicamentos por via transdermica | |
DK239288D0 (da) | Transdermal absorptionsdosisenhed til narkotiske analgetika og antagonister | |
EP0388306A3 (en) | Method for treating pain associated with herpes-zoster and post-herpetic neuralgia by topical application of local anesthetics | |
HU906356D0 (en) | Plaster containing oestrogenic active agents, and process for the preparation of such plasters | |
ATE109357T1 (de) | Transdermales estradiol als therapeutisches sytem. | |
KR960703545A (ko) | 테스토스테론의 공급을 위한 피부패치 및 방법(skin patches and methods for providing testosterone) | |
KR920700602A (ko) | 폐경기후의 증후군을 치료하기 위한 경피 흡수 투여 단위 및 투여 방법 | |
SE9703191L (sv) | Läkemedel för förbättring av muskelfunktionsdurationen eller behandling av muskelstörningar eller -sjukdom | |
FI900315A0 (fi) | Saett att framstaella ett ytligt terapeutiskt system vilket innehaoller tillvaext av elakartade celler och tillvaextfoerhindrande aktivaemne, speciellt 5-fluoruracil. | |
AR003979A1 (es) | Administracion transdermica de vorozol. | |
AU6229086A (en) | Novel transdermal anti-anginal pharmaceutical dosage unit and process for its administration | |
JPS6016921A (ja) | 貼付薬 | |
PL332035A1 (en) | Transdermal therapeutic system including an estriol-containing composition of active substances |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD | Application lapsed | ||
FD | Application lapsed |
Owner name: RUTGERS, THE STATE UNIVERSITY OF |